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Centrosomes are complex cellular substructures that are
dynamically regulated by a series of biochemical and mor-
phological changes that parallel the progression of the cell
cycle. In addition to organizing cytoplasmic microtubule
arrays during interphase, centrosomes direct formation and
positioning of the bipolar mitotic spindle and thereby
enable equal partitioning of chromosomal material during
mitosis. Because impaired centrosomal function during cell
division has the potential to cause chromosomal missegre-
gation, and thus lead to genetic instability, the centrosome
has become an important focus for cancer research. In
fact, many tumor cells, including those from the breast,
exhibit excessive numbers of centrosomes and/or centro-
somes with aberrant morphologies. A collection of recent
papers, some of which challenge prevailing dogmas,
provide new insight into the biology of the metazoan cen-
trosome cycle (i.e., duplication, maturation and separation)
and elucidate novel regulatory pathways that are reason-
able targets for oncogenic therapy development.
Given the correlation between centrosome number and
tumor progression, molecules regulating centrosomal
duplication at the G1/S transition have been under con-
siderable scrutiny. Fisk and Winey recently used a culture-
based assay of centrosome duplication to query the
relevance of mMps-1p, the mouse orthologue of the Sac-
charomyces cerevisiae MPS1p protein kinase, a protein
known to regulate spindle pole body replication (Cell
2001, 106:95-104). While overexpression of wild-type
mMps-1p promotes excessive duplication events, a
kinase-inactive form of mMps-1p exerts a dominant nega-
tive effect antagonizing centrosome replication. Further-
more, mMps-1p protein stability, and thus function, is
regulated via phosphorylation through cyclin-dependent
kinase 2 (CDK2), a known mediator, and possible coordi-
nator, of DNA replication and centrosomal duplication.
Matsumoto and Maller have demonstrated that, in the
context of S-phase-arrested Xenopus extracts, it is
calcium/calmodulin-dependent kinase (CaMKII), and not
CDK2, that actually initiates centrosomal duplication
(Science 2002, 295:499-502). CaMKII is likely triggered
in response to the periodic calcium oscillations that occur
at the G1/S transition and are required for centrosome
duplication. Finally, a provocative study by Khodjakov et al.
challenges the concept that centrosome replication is an
obligate semi-conservative process (J Cell Biol 2002,
158:1171-1181). They show that new centrosomes form
de novo in S phase-arrested cells in which centrosomes
have been removed by laser ablation. This finding not only
raises important questions regarding centrosome duplica-
tion checkpoints but also suggests that tumor-associated
centrosome amplification could conceivably be attributed
to de novo synthesis events.
Aurora serine/threonine kinases have received recent
attention as critical regulators of the cell and centrosome
cycle. One family member, called Aurora A, is over-
expressed in many tumors and is found in the 20q13
breast cancer amplicon. In cultured cells, over-expression
of Aurora A results in centrosome amplification and aneu-
ploidy. Recent results indicate that Aurora A is an impor-
tant determinant of centrosome maturation. Hannak et al.
employed an RNAi strategy to query the role of
Caenorhabditis elegans Aurora A (or AIR-1) during the
first embryonic cell division (J Cell Biol 2001, 155:1109-
1116). AIR-1 depletion resulted in the incomplete separa-
tion of centrosomes, an event likely due to the impaired
accumulation of γ-tubulin and other pericentriolar compo-
nents required for centrosome maturation. Aurora A deple-
tion in Drosophila also induces centrosomal maturation
and spindle defects. For example, Giet and colleagues
showed that in both neuroblasts and syncytial embryos,
mutations in Aurora A lead to a decrease in the length of
astral microtubules and to a disorganization of centro-
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somes (J Cell Biol 2002, 156:437-451). Aurora A-
depleted cells also displayed mitotic spindles with gross
metaphase defects. Moreover, reduced Aurora A function
correlated with aberrant centrosomal recruitment of the D-
TACC/MSPS complex, which plays a role in the regulation
of astral microtubules of the spindle. Likewise, in an inde-
pendent study of Drosophila sensory organ precursor
cells, Berdnik and Knoblich showed that mutations in
Aurora A impair centrosomal accumulation of both centro-
somin and γ-tubulin and give rise to spindle defects (Curr
Biol 2002, 12:640-647).
The genetic models described above argue strongly for a
role for Aurora A in centrosome maturation and suggest
that perturbed Aurora A function has severe consequences
on spindle function during subsequent mitotic progression.
A recent study by Meraldi et al. in cultured cells has sug-
gested that Aurora A over-expression induces centrosomal
amplification, not by modulating duplication machinery, but
by promoting aberrant mitosis and cytokinesis (Embo J
2002, 21:483-492). Aurora A-induced malfunctions lead
to an abundance of multinucleated cells and a seeming
amplification of what are actually normally duplicated cen-
trosomes. This assessment is further supported by the fact
that centrosome amplification is exacerbated in cells defec-
tive in the mitotic checkpoint protein p53. Collectively,
these studies demonstrate the importance of Aurora A as a
target for cancer study. In this regard, a recent structural
analysis, by Cheetham and colleagues, of Aurora A high-
lights a number of features unique to this kinase (J Biol
Chem 2002, 277:42419-42422), and in doing so pro-
vides potentially useful information for the development of
specific Aurora A modulators.
Other centrosomal constituents of recent notice are cen-
trosomal Nek2-associated protein 1(C-Nap1) and the
Rho-dependent protein kinase, p160ROCK, both of which
appear to be involved in centrosome organization via their
contributions to intercentriolar linkages. C-Nap1 localizes
preferentially to the ends of parental centrioles and has
been implicated in cell-cycle-regulated cohesion of centro-
somes following duplication. Mayor and colleagues
recently showed that C-Nap1 is phosphorylated at the
onset of mitosis. This phosphorylation drives dissociation
of C-Nap1 from the centrioles, and may thereby contribute
to centrosome separation leading to bipolar spindle forma-
tion (J Cell Sci 2002, 115:3275-3284). p160ROCK,
which was originally identified from a panel of centrosome-
directed monoclonal antibodies, plays a role in intercentri-
olar positioning. Chevrier et al. have shown that within a
single centrosome, p160ROCK localizes to the maternal
centriole and the intercentriolar linker (J Cell Biol 2002,
157:807-817). p160ROCK-specific inhibitors induced
centriole separation in G1 cells and caused accelerated
movement of the maternal centriole to the midplate after
mitosis. Thus, p160ROCK is an important regulator of
centrosome organization and positioning throughout the
cell cycle.
Clearly, irregularities in centrosome duplication, maturation
and/or separation have potential to wreak havoc on the
fidelity of mitotic events. Presumably, these centrosomal
defects contribute to tumor cell aneuploidy, which is
observed in many human cancers. Given the abundance of
centrosome cycle regulators, it is likely that studies such as
those described above will contribute to the development
of important cancer diagnostics and/or therapies.
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